Natural Product (NP) Details
General Information of the NP (ID: NP6396) | |||||
---|---|---|---|---|---|
Name |
Ulinastatin
|
||||
Synonyms |
Urinastatin; Urinary trypsin inhibitor; Trypsin inhibitor MR-20; MR-20 (Magnetic powder); Uti(68); Acid-stable protease inhibitor; Urinary trypsin inhibitor (68); 2,4-Dioxaspiro[5.5]undec-8-ene, 3-(2-furanyl)-; 80449-31-6; Urinary trypsin inhibitor-like inhibitor (43); Trypsin inhibitor (human urine urinastatin protein moiety); 80449-32-7; 2,4-Dioxaspiro(5.5)undec-8-ene, 3-(2-furanyl)-; Miraclid; AC1L2Y1N; UTI68; 3-(2-Furanyl)-2,4-dioxaspiro(5.5)undec-8-ene; AC1Q70L4; AKOS025401879; CS-7119; MR 20 (magnetic p
Click to Show/Hide
|
||||
Species Origin | Homo sapiens ... | Click to Show/Hide | |||
Homo sapiens | |||||
Disease | Preterm labour/delivery [ICD-11: JB00] | Phase 3 | [1] | ||
Structure |
![]() |
Click to Download Mol2D MOL |
|||
Click to Show/Hide the Molecular Information and External Link(s) of This Natural Product | |||||
Formula |
C13H16O3
|
||||
PubChem CID | |||||
Canonical SMILES |
C1CC2(CC=C1)COC(OC2)C3=CC=CO3
|
||||
InChI |
1S/C13H16O3/c1-2-6-13(7-3-1)9-15-12(16-10-13)11-5-4-8-14-11/h1-2,4-5,8,12H,3,6-7,9-10H2
|
||||
InChIKey |
ODVKSTFPQDVPJZ-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 80449-31-6
|
||||
Herb ID | |||||
TTD Drug ID |
Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
---|---|---|---|---|---|---|
α. A List of Drug(s) Whose Efficacy can be Enhanced by This NP | ||||||
5-fluorouracil | Solid tumour/cancer | Click to Show/Hide the Molecular Data of This Drug | ||||
Achieving Therapeutic Synergy | Click to Show/Hide | |||||
Representative Experiment Reporting the Effect of This Combination | [2] | |||||
Detail(s) |
Combination Info
![]() |
|||||
Molecule(s)
Regulation |
Down-regulation | Expression | WNT3A | Molecule Info |
Pathway MAP
|
|
In-vitro Model | Huh-7 | CVCL_0336 | Adult hepatocellular carcinoma | Homo sapiens | ||
Experimental
Result(s) |
UTI enhanced the 5-FU sensitivity of HCC cells by attenuating their stemness via inhibiting Wnt/Beta-catenin signaling. |
Target and Pathway | ||||
---|---|---|---|---|
Target(s) | Trypsin-1 (PRSS1) | Molecule Info | [1] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | Click to Show/Hide | ||
2 | Pancreatic secretion | |||
3 | Protein digestion and absorption | |||
4 | Influenza A | |||
Reactome | Activation of Matrix Metalloproteinases | Click to Show/Hide | ||
2 | Cobalamin (Cbl, vitamin B12) transport and metabolism | |||
WikiPathways | Activation of Matrix Metalloproteinases | Click to Show/Hide |
